Managing dry eye disease and facilitating realistic patient expectations: a review and appraisal of current therapies

B Shen Lee, AG Kabat, J Bacharach… - Clinical …, 2020 - Taylor & Francis
Dry eye disease (DED) is a multifactorial disease of the ocular surface characterized by loss
of homeostasis of the tear film and accompanied by ocular signs and symptoms such as …

The effect of immunologically safe plasma rich in growth factor eye drops in patients with Sjögren syndrome

RM Sanchez-Avila, J Merayo-Lloves… - Journal of Ocular …, 2017 - liebertpub.com
Purpose: The objective was to provide preliminary information about the efficacy and safety
of immunologically safe plasma rich in growth factor (immunosafe PRGF) eye drops in the …

Burning eye syndrome: do neuropathic pain mechanisms underlie chronic dry eye?

JP Kalangara, A Galor, RC Levitt, ER Felix… - Pain …, 2016 - academic.oup.com
Objective. Dry eye is a multi-factorial disorder that manifests with painful ocular symptoms
and visual disturbances, which can only be partly attributed to tear dysfunction. This disorder …

Long-term use of autologous serum 50% eye drops for the treatment of dry eye disease

M Hussain, RM Shtein, A Sugar, HK Soong… - Cornea, 2014 - journals.lww.com
Purpose: The aim of this study was to describe the outcomes of 50% autologous serum (AS)
eye drops after long-term use in a large cohort of patients with dry eyes. Methods: A …

Omega‐3 fatty acids in the management of dry eye disease—An updated systematic review and meta‐analysis

C O'Byrne, M O'Keeffe - Acta ophthalmologica, 2023 - Wiley Online Library
Purpose The purpose of this study was to examine the effectiveness of omega‐3 fatty acids
in comparison to a placebo in the management of dry eye disease. Methods A systematic …

[HTML][HTML] Ophthalmologic manifestations of primary Sjögren's syndrome

AM Roszkowska, GW Oliverio, E Aragona, L Inferrera… - Genes, 2021 - mdpi.com
Sjögren's syndrome (SS) is a chronic, progressive, inflammatory, autoimmune disease,
characterized by the lymphocyte infiltration of exocrine glands, especially the lacrimal and …

Autologous serum eye drops for ocular surface disorders

D Cui, G Li, EK Akpek - Current opinion in allergy and clinical …, 2021 - journals.lww.com
Autologous serum eye drops for ocular surface disorders : Current Opinion in Allergy and
Clinical Immunology Autologous serum eye drops for ocular surface disorders : Current Opinion …

Autologous serum eye drops versus artificial tear drops for dry eye disease: a systematic review and meta-analysis of randomized controlled trials

L Wang, K Cao, Z Wei, C Baudouin, A Labbé… - Ophthalmic …, 2020 - karger.com
Objective: To compare the efficacy of autologous serum (AS) eye drops and artificial tears
(AT) in dry eye disease (DED). Methods: Five databases (PubMed, Science Direct, the …

[HTML][HTML] The comparison between the composition of 100% autologous serum and 100% platelet-rich plasma eye drops and their impact on the treatment …

D Wróbel-Dudzińska, A Przekora… - Journal of Clinical …, 2023 - mdpi.com
Purpose: The aim of the study was to compare the difference in composition between 100%
autologous serum (AS) and 100% platelet-rich plasma (PRP) eye drops and assess their …

[HTML][HTML] Clinical associations of corneal neuromas with ocular surface diseases

CJL Toh, C Liu, IXY Lee, MTY Lin… - Neural Regeneration …, 2024 - journals.lww.com
Corneal neuromas, also termed microneuromas, refer to microscopic, irregularly-shaped
enlargements of terminal subbasal nerve endings at sites of nerve damage or injury. The …